Navigation Links
Almost Family to Present at Two Upcoming Conferences
Date:5/8/2009

LOUISVILLE, Ky., May 8 /PRNewswire-FirstCall/ -- Almost Family, Inc. (Nasdaq: AFAM), a leading regional provider of home health nursing services, announced today that William Yarmuth, President and Chief Executive Officer, and Steve Guenthner, Senior Vice President and Chief Financial Officer, are scheduled to present at two upcoming investor conferences. The first presentation will be at the Robert W. Baird & Co. 2009 Growth Stock Conference at the Four Seasons Hotel in Chicago, IL.

           Event:  Robert W. Baird & Co. 2009 Growth Stock Conference
           Date:   Wednesday, May 13, 2009
           Time:   10:05 a.m. CT

The second presentation will be at the Bank of America and Merrill Lynch 2009 Healthcare Conference at the Palace Hotel in New York, NY.

           Event: Bank of America and Merrill Lynch 2009 Healthcare Conference
           Date:  Thursday, May 14, 2009
           Time:  9:20 a.m. ET

An audio Web cast of the Company's presentations will be available by visiting the investor relations section of Almost Family's Web site at www.almostfamily.com. A replay of the presentations will be available for 30 days.

About Almost Family

Almost Family, Inc., founded in 1976, is a leading regional provider of home health nursing services, with branch locations in Florida, Kentucky, Connecticut, New Jersey, Ohio, Massachusetts, Alabama, Missouri, Illinois, Pennsylvania, and Indiana (in order of revenue significance). Almost Family, Inc. and its subsidiaries operate a Medicare-certified segment and a personal care segment. Altogether, Almost Family operates over 90 branch locations in 11 U.S. states.

Forward Looking Statement

All statements, other than statements of historical facts, included in this news release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as "may," "will," "expect," "believe," estimate," "project," anticipate," "continue," or similar terms, variations of those terms or the negative of those terms. These forward- looking statements are based on the Company's current plans, expectations and projections about future events.

Because forward-looking statements involve risks and uncertainties, the Company's actual results could differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. For a more complete discussion regarding factors which could affect the Company's financial performance, refer to the Company's various filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise its forward-looking statements.

       Almost Family, Inc.                The Ruth Group
       Steve Guenthner                    Investor Relations
       (502) 891-1000                     Nick Laudico / Zack Kubow
                                          (646) 536-7030 / 7020
                                          nlaudico@theruthgroup.com
                                          zkubow@theruthgroup.com


'/>"/>
SOURCE Almost Family, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Almost a Third of U.S. Kids Use Supplements
2. Almost Family Named One of Ten Best Newcomers to Forbes Magazine 200 Best Small Companies
3. Almost 90 percent of children reported experiencing sexual violence
4. Doctors Applaud SCHIP Veto: Bill Supports Special Interests, Not Kids; Almost Half of Funds Go to Doctors & Seniors
5. Almost 2 Million U.S. Vets Lack Health Insurance
6. Almost 1 in 5 Americans Going Without Health Care
7. Almost Family Announces Expansion of Revolving Credit Facility
8. Cancer Killed Almost 8 Million Worldwide in 2007
9. Almost Half of Doctors Have Prescribed Placebos
10. Almost Half of 10-Year-Olds Have Tasted Alcohol
11. Using the safety belt in the rear seats of the car reduces death risk by almost a half
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental Laboratories ... and patients about the safety issues related to dental restorations. According to the American ... projected to reach $6.4 billion in 2018 with more than 30 million Americans missing ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: